Archive - Life Sciences Archive

Astex Technology, the private, structure-based drug discovery company, and Maybridge plc, a world leader in the supply of small molecule screening compounds, building blocks and associated chemistries, are collaborating based on in silico screening of proprietary molecular libraries and synthetic chemistry.

Astex and Maybridge will collaborate to construct a proprietary in silico library from Maybridge’s heterocyclic chemistry derived from their 40 years of proven expertise in this field.

Astex will use this library as part of their in silico and experimental X-ray crystallographic structural screening against targets in Astex’s portfolio.

Active compounds will be rapidly optimised using Astex’s proprietary structure based design tools.